Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects.
about
Biomarkers and molecular probes for cell death imaging and targeted therapeuticsSquamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects.Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography.Non-invasive imaging for studying anti-angiogenic therapy effects.Bis(zinc-dipicolylamine), Zn-DPA, a new marker for apoptosis.Advantages of the phosphatidylserine-recognizing peptide PSP1 for molecular imaging of tumor apoptosis compared with annexin VNon-invasive in vivo imaging of arthritis in a collagen-induced murine model with phosphatidylserine-binding near-infrared (NIR) dye.Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI.Multicolor fluorescence imaging of traumatic brain injury in a cryolesion mouse modelOptical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator.Phenoxide-Bridged Zinc(II)-Bis(dipicolylamine) Probes for Molecular Imaging of Cell Death.Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial BioparametersRadiopharmaceuticals as probes to characterize tumour tissue.Apoptosis imaging studies in various animal models using radio-iodinated peptide.Hybrid µCT-FMT imaging and image analysis.A low molecular weight zinc2+-dipicolylamine-based probe detects apoptosis during tumour treatment better than an annexin V-based probe.Fluorescence Detection of Cell Death in Liver of Mice Treated with Thioacetamide.
P2860
Q26866387-00031A80-B2FA-4773-959D-5906647FF0ACQ30357817-8AC53C4F-B54A-4437-AEB9-87DD30189525Q30432543-9075909D-92F5-4018-9A25-6B73863866FCQ30447988-2E63EDFD-F4C6-401C-9D21-E7099D893EFFQ34020752-A3667A01-07FD-4804-9737-9455F134D0FEQ35214262-53AB79C3-DF70-406D-9B42-DDFFCE2DE36AQ35409766-E5C40F1A-7361-4581-BFAC-B1A93C7E37FBQ35783407-1D5C0546-7807-4C68-AF00-1818FB076E46Q36104487-FFA50A9E-6F47-4FC6-9841-64ED8ABB0205Q36586529-2804DE20-E48A-4FA7-94CD-114306049D7FQ37030890-DFCE20E9-A3FC-4E32-A1C9-3F816978004CQ37291272-8685F4EC-207E-4064-9169-6C2EF23AAF07Q38342458-A5206751-B8AA-4A4C-A66E-C8519AB6F7F2Q38937295-9CB691AB-B791-435B-BA27-5961E0BC481FQ40845003-C741804E-0FF8-4C39-BB52-64E80B60BD8AQ47205315-B131F5E2-AE02-4EE5-A676-864E2850361FQ49678058-494AE0C1-B8E9-4CA6-BE63-8C7F4CC4DE74
P2860
Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Failure of annexin-based apopt ...... ntiangiogenic therapy effects.
@ast
Failure of annexin-based apopt ...... ntiangiogenic therapy effects.
@en
type
label
Failure of annexin-based apopt ...... ntiangiogenic therapy effects.
@ast
Failure of annexin-based apopt ...... ntiangiogenic therapy effects.
@en
prefLabel
Failure of annexin-based apopt ...... ntiangiogenic therapy effects.
@ast
Failure of annexin-based apopt ...... ntiangiogenic therapy effects.
@en
P2093
P2860
P356
P1433
P1476
Failure of annexin-based apopt ...... ntiangiogenic therapy effects.
@en
P2093
Dennis Doleschel
Fabian Kiessling
Felix Gremse
Felix M Mottaghy
Jörn Schmaljohann
Moritz Palmowski
Susanne Arns
Wiltrud Lederle
P2860
P2888
P356
10.1186/2191-219X-1-26
P577
2011-11-17T00:00:00Z
P5875
P6179
1015717624